drug

ALN-4915

1 story · latest Oct 15, 2026

Follow ALN-4915. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Alnylam Pharmaceuticals

Timeline

Alnylam's Phase 1 trial of ALN-4915 in healthy volunteers is active, not recruiting

Oct 15Trial updateALN-4915 Alnylam Pharmaceuticals

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.